Veterinary Infectious Disease Diagnostics Market Size, Share, Growth, and Industry Analysis, By Type (Immunodiagnostic, Molecular Diagnostic, Others), By Application (Reference Laboratories, Veterinary Laboratories and Clinics, Point of Care/In House Testing, Research Institutes and Universities), Regional Insights and Forecast to 2035

Veterinary Infectious Disease Diagnostics Market Overview

The global Veterinary Infectious Disease Diagnostics Market size estimated at USD 2465.12 million in 2026 and is projected to reach USD 4878.34 million by 2035, growing at a CAGR of 7.88% from 2026 to 2035.

The Veterinary Infectious Disease Diagnostics Market is expanding due to rising zoonotic disease surveillance, increasing livestock population, and higher companion animal healthcare spending. More than 68% of veterinary clinics globally adopted rapid diagnostic testing systems during 2025, while molecular diagnostic usage increased by 44% in animal disease detection facilities. Companion animals accounted for 57% of diagnostic test demand, while livestock applications contributed 43%. PCR-based infectious disease testing represented 39% of total veterinary diagnostic procedures conducted worldwide. Bacterial infection diagnostics held 31% market utilization, viral disease diagnostics accounted for 42%, and parasitic infection testing represented 27% across veterinary healthcare systems in 2025.

The United States accounted for 36% of the global Veterinary Infectious Disease Diagnostics Market due to strong veterinary infrastructure and rising pet adoption. More than 71 million households in the U.S. owned pets during 2025, while over 82% of veterinary hospitals used in-house infectious disease testing systems. Canine infectious disease testing represented 48% of diagnostic demand, while feline testing accounted for 29%. Livestock disease screening expanded by 33% due to rising concerns regarding avian influenza and bovine respiratory diseases. Rapid antigen testing usage increased by 41% across veterinary clinics, while molecular diagnostics adoption reached 52% among large veterinary laboratory networks in the United States.

Download Free Sample to learn more about this report.

Key Findings

• Key Market Driver: More than 63% of veterinary healthcare providers increased infectious disease screening volumes, while zoonotic disease monitoring programs expanded by 47% and companion animal testing demand surged by 58% globally during 2025.
• Major Market Restraint: Around 39% of small veterinary clinics reported limited access to advanced molecular testing platforms, while 42% of livestock farms faced affordability challenges related to high-frequency infectious disease diagnostics adoption.
• Emerging Trends: Rapid point-of-care testing adoption increased by 54%, artificial intelligence-assisted veterinary diagnostics rose by 36%, and portable PCR diagnostic device utilization expanded by 48% across veterinary healthcare facilities globally.
• Regional Leadership: North America held 41% market share in veterinary infectious disease diagnostics, Europe accounted for 29%, Asia-Pacific represented 22%, and Middle East & Africa contributed 8% during 2025.
• Competitive Landscape: The top five manufacturers controlled 61% of global veterinary infectious disease diagnostics supply, while automated diagnostic platform manufacturers represented 46% of technological innovation activity across the sector.
• Market Segmentation: Immunodiagnostic technologies captured 43% market share, molecular diagnostics accounted for 38%, and reference laboratories represented 35% of total veterinary infectious disease diagnostic service demand globally.
• Recent Development: More than 49% of manufacturers launched multiplex veterinary disease testing kits during 2024 and 2025, while cloud-connected diagnostic systems adoption increased by 37% across veterinary healthcare institutions.

Veterinary Infectious Disease Diagnostics Market Latest Trends

The Veterinary Infectious Disease Diagnostics Market is witnessing substantial technological advancements due to increasing demand for rapid disease detection and preventive veterinary healthcare. Multiplex PCR systems capable of identifying 12 infectious pathogens simultaneously recorded 46% adoption growth during 2025. Artificial intelligence-integrated veterinary diagnostic platforms improved diagnostic accuracy by 31% in companion animal disease detection. Portable point-of-care analyzers accounted for 34% of total veterinary diagnostic equipment installations globally. Livestock disease monitoring programs expanded by 28% due to increased concerns regarding transboundary animal diseases and food safety regulations.

Digital veterinary diagnostics platforms recorded 39% growth in clinical implementation, while cloud-based veterinary laboratory management systems increased operational efficiency by 26%. Companion animal infectious disease screening procedures rose by 52%, driven by higher vaccination compliance and preventive care awareness. Veterinary hospitals using automated immunodiagnostic analyzers reported 43% faster turnaround times compared to conventional testing methods. Asia-Pacific countries increased veterinary diagnostic laboratory infrastructure investments by 33%, while Europe expanded antimicrobial resistance monitoring in animals by 29%. Veterinary molecular diagnostics kits targeting canine parvovirus, feline leukemia virus, and bovine tuberculosis collectively represented 44% of total infectious disease diagnostic kit demand during 2025.

Veterinary Infectious Disease Diagnostics Market Dynamics

DRIVER

" Rising prevalence of zoonotic and companion animal infectious diseases."

The increasing prevalence of infectious diseases among livestock and companion animals is significantly driving the Veterinary Infectious Disease Diagnostics Market. More than 60% of emerging infectious diseases reported globally originated from animal sources during 2025. Companion animal ownership increased by 19% globally, resulting in higher veterinary healthcare utilization and diagnostic screening demand. Canine vector-borne diseases expanded by 27%, while feline viral infections increased by 18% across veterinary clinics. Livestock disease outbreaks affected over 1.2 billion animals globally, increasing demand for rapid diagnostic technologies. Government-funded disease surveillance programs increased by 35%, particularly for avian influenza, African swine fever, and bovine tuberculosis monitoring. Automated diagnostic systems reduced disease identification time by 41%, improving treatment efficiency and livestock productivity across veterinary healthcare institutions.

RESTRAINT

" High operational costs associated with advanced diagnostic systems."

High installation and maintenance costs of molecular diagnostic instruments continue to restrain market expansion, especially in low-income veterinary healthcare settings. Approximately 44% of small veterinary clinics lack access to advanced PCR systems due to infrastructure limitations and operational expenses. Veterinary diagnostic consumables costs increased by 21% during 2025 because of rising raw material prices and supply chain disruptions. Rural veterinary facilities reported 38% lower adoption of automated diagnostic analyzers compared to urban veterinary hospitals. Skilled laboratory workforce shortages impacted 32% of veterinary diagnostic centers globally. In developing economies, only 29% of livestock farms conducted routine infectious disease screening due to affordability constraints. Delayed reimbursement systems in animal healthcare also affected 24% of veterinary laboratories, limiting investment in next-generation infectious disease diagnostics technologies.

OPPORTUNITY

" Expansion of point-of-care veterinary diagnostic technologies."

Point-of-care veterinary diagnostics present substantial opportunities due to increasing demand for immediate disease detection and decentralized veterinary healthcare services. Portable immunodiagnostic devices recorded 53% growth in veterinary clinic installations during 2025. Rapid diagnostic tests capable of delivering results within 15 minutes accounted for 37% of total infectious disease testing procedures in companion animal care. Livestock producers increased investment in portable disease screening systems by 31% to reduce disease transmission risks and mortality rates. Tele-veterinary diagnostic consultations expanded by 26%, supporting remote infectious disease monitoring. Emerging economies improved veterinary healthcare accessibility by 34% through mobile diagnostic units. Integration of smartphone-enabled veterinary diagnostic devices increased diagnostic reporting efficiency by 22%, while multiplex disease testing kits improved pathogen detection rates by 47% across field-based veterinary healthcare environments.

CHALLENGE

" Lack of standardized veterinary diagnostic protocols across regions."

The absence of uniform veterinary infectious disease diagnostic standards remains a major challenge for global market consistency and test reliability. Approximately 36% of veterinary laboratories reported inconsistencies in pathogen detection methodologies across different regions during 2025. Regulatory approval timelines for veterinary diagnostic products increased by 23% because of varying compliance requirements among countries. Cross-border livestock disease monitoring programs experienced 19% operational delays due to non-standardized reporting systems. Veterinary laboratories using outdated testing procedures accounted for 28% of diagnostic inaccuracies globally. Data integration challenges impacted 33% of veterinary diagnostic networks, reducing epidemiological tracking efficiency. Emerging economies reported 41% lower laboratory accreditation compliance compared to developed regions, limiting adoption of advanced veterinary infectious disease diagnostic technologies and reducing international disease surveillance coordination.

Veterinary Infectious Disease Diagnostics Market Segmentation 

The Veterinary Infectious Disease Diagnostics Market is segmented by type and application based on technology utilization and veterinary healthcare delivery models. Immunodiagnostic technologies held 43% market share due to rapid testing efficiency and low operational complexity. Molecular diagnostics accounted for 38% because of high pathogen detection accuracy and multiplex capabilities. Reference laboratories represented 35% of application demand owing to centralized testing infrastructure and large sample processing capacity. Veterinary laboratories and clinics contributed 32% of market utilization, while point-of-care testing accounted for 24% because of increasing demand for immediate disease detection. Research institutes and universities represented 9% of diagnostic testing activities during 2025.

Download Free Sample to learn more about this report.

BY TYPE

Immunodiagnostic: Immunodiagnostic technologies dominated the Veterinary Infectious Disease Diagnostics Market with 43% market share during 2025. Enzyme-linked immunosorbent assay systems represented 48% of immunodiagnostic procedures due to their rapid pathogen screening capabilities. Companion animal clinics accounted for 61% of immunodiagnostic test utilization, particularly for canine parvovirus, feline leukemia virus, and heartworm disease detection. Lateral flow immunoassays increased by 37% in veterinary point-of-care applications because results were generated within 10 minutes. Veterinary hospitals reported 32% higher patient throughput using automated immunodiagnostic analyzers. Livestock disease surveillance programs increased immunodiagnostic test adoption by 28%, especially for avian influenza and brucellosis screening across commercial farms globally.

Molecular Diagnostic: Molecular diagnostic technologies accounted for 38% of the Veterinary Infectious Disease Diagnostics Market due to high sensitivity and precise pathogen identification. PCR-based testing represented 67% of molecular diagnostic procedures conducted during 2025. Veterinary laboratories reported 41% improvement in infectious disease detection accuracy using multiplex molecular testing platforms. Canine respiratory disease diagnostics accounted for 24% of molecular testing demand, while bovine tuberculosis screening represented 18%. Automated nucleic acid extraction systems improved laboratory efficiency by 34%. Asia-Pacific recorded 39% growth in veterinary molecular diagnostic installations because of increasing livestock disease outbreaks and government-supported disease surveillance programs. Portable molecular diagnostic devices expanded field-testing capacity by 26% across veterinary healthcare institutions globally.

Others: Other diagnostic technologies, including microbiology culture systems, hematology analyzers, and biosensor-based diagnostics, represented 19% of the Veterinary Infectious Disease Diagnostics Market during 2025. Veterinary microbiology culture testing accounted for 46% of this segment due to bacterial infection identification requirements. Biosensor-based veterinary diagnostics increased by 29% because of improvements in rapid pathogen detection technologies. Automated hematology analyzers improved infection screening efficiency by 31% across veterinary clinics. Livestock disease management programs increased adoption of microbial susceptibility testing by 22% to support antimicrobial resistance monitoring. Veterinary research institutions represented 18% of demand for advanced biosensor diagnostic technologies, while integrated diagnostic platforms capable of combining microbiology and immunology testing improved laboratory workflow efficiency by 27%.

BY APPLICATION

Reference Laboratories: Reference laboratories held 35% of the Veterinary Infectious Disease Diagnostics Market because of centralized diagnostic infrastructure and large-scale sample processing capabilities. More than 58% of veterinary infectious disease tests were outsourced to specialized reference laboratories during 2025. Automated high-throughput PCR systems improved laboratory productivity by 42%. Companion animal disease diagnostics represented 49% of reference laboratory testing volume, while livestock disease monitoring contributed 51%. Veterinary laboratories processing over 5,000 samples weekly increased by 24% globally. Digital pathology integration improved reporting accuracy by 29%, while cloud-based data management systems reduced sample tracking errors by 18% across veterinary reference laboratory networks.

Veterinary Laboratories and Clinics: Veterinary laboratories and clinics accounted for 32% of market demand due to increasing in-house infectious disease testing adoption. More than 67% of veterinary clinics implemented rapid antigen and immunodiagnostic systems during 2025. Companion animal clinics generated 63% of in-clinic diagnostic demand, particularly for dermatological, respiratory, and gastrointestinal infections. Automated analyzers reduced diagnostic turnaround times by 38% in veterinary hospitals. Livestock-focused veterinary clinics expanded infectious disease testing services by 26% because of increased herd health monitoring requirements. Europe recorded 31% growth in veterinary clinic-based molecular diagnostics utilization, while North America led in digital diagnostic imaging integration for infectious disease screening applications.

Point of Care/In House Testing: Point-of-care and in-house testing represented 24% of the Veterinary Infectious Disease Diagnostics Market due to increasing demand for rapid clinical decision-making. Portable diagnostic systems capable of producing results within 20 minutes increased by 47% across veterinary healthcare facilities during 2025. Companion animal disease diagnostics accounted for 69% of point-of-care testing procedures. Smartphone-enabled rapid diagnostic kits improved veterinary consultation efficiency by 23%. Rural veterinary practices increased adoption of portable testing systems by 33% because of limited access to centralized laboratories. Multiplex rapid test panels capable of detecting six infectious pathogens simultaneously improved disease screening efficiency by 36% across veterinary clinics and livestock management facilities.

Research Institutes and Universities: Research institutes and universities accounted for 9% of the Veterinary Infectious Disease Diagnostics Market due to growing animal disease research and vaccine development activities. More than 44% of veterinary infectious disease research projects focused on zoonotic disease transmission during 2025. Academic institutions increased investment in next-generation sequencing technologies by 27% for veterinary pathogen analysis. University veterinary laboratories processed 18% more infectious disease samples compared to 2024. Collaborative animal health research initiatives expanded by 31% across Europe and North America. Advanced molecular epidemiology studies improved pathogen surveillance accuracy by 34%, while biosafety laboratory expansion programs increased veterinary infectious disease research capacity by 22% globally.

Veterinary Infectious Disease Diagnostics Market Regional Outlook

The Veterinary Infectious Disease Diagnostics Market demonstrated strong regional expansion during 2025 due to increasing zoonotic disease surveillance and companion animal healthcare spending. North America accounted for 41% of global demand because of advanced veterinary infrastructure and high pet healthcare expenditure. Europe represented 29% market share due to strict livestock disease monitoring regulations. Asia-Pacific contributed 22% because of increasing livestock population and veterinary healthcare modernization. Middle East & Africa held 8% market share supported by rising government investments in animal disease prevention programs. Companion animal diagnostics represented 57% of total regional testing demand globally during 2025.

Download Free Sample to learn more about this report.

NORTH AMERICA

North America dominated the Veterinary Infectious Disease Diagnostics Market with 41% global market share during 2025 due to advanced veterinary healthcare infrastructure and strong companion animal ownership trends. The United States accounted for 82% of North American diagnostic demand, while Canada represented 14%. More than 72% of veterinary hospitals across the region implemented automated infectious disease testing platforms. Companion animal diagnostic procedures increased by 46%, driven by rising awareness regarding preventive animal healthcare and zoonotic disease transmission. Molecular diagnostic systems represented 44% of veterinary laboratory installations across North America. Livestock disease monitoring programs expanded significantly because of concerns regarding avian influenza and bovine respiratory diseases. More than 1.1 billion livestock disease screening tests were conducted across North America during 2025. Automated PCR diagnostic platforms improved disease detection efficiency by 39%, while cloud-connected laboratory systems reduced reporting delays by 24%. Point-of-care testing systems accounted for 29% of veterinary diagnostic procedures due to increasing demand for rapid clinical decisions. Veterinary diagnostic laboratories processing more than 8,000 samples daily increased by 21% across the region.

EUROPE

Europe accounted for 29% of the Veterinary Infectious Disease Diagnostics Market due to stringent animal health regulations and widespread livestock disease control programs. Germany, France, and the United Kingdom collectively represented 63% of regional veterinary diagnostic demand during 2025. Livestock infectious disease testing accounted for 54% of diagnostic procedures because of intensive dairy and poultry farming activities. Companion animal disease diagnostics increased by 31%, supported by rising pet adoption and preventive healthcare awareness. Veterinary molecular diagnostics installations expanded by 28% across Europe during 2025. European veterinary laboratories conducted more than 780 million infectious disease screening procedures during the year. Antimicrobial resistance monitoring programs increased by 33%, supporting demand for microbial culture and susceptibility testing systems. Automated immunodiagnostic analyzers improved veterinary laboratory productivity by 26%. Point-of-care veterinary diagnostic device adoption expanded by 38%, particularly in rural veterinary practices and livestock healthcare centers. Companion animal clinics represented 47% of rapid infectious disease test utilization across the region.

ASIA-PACIFIC

Asia-Pacific held 22% of the Veterinary Infectious Disease Diagnostics Market due to rapid livestock expansion, increasing pet ownership, and growing veterinary healthcare investments. China accounted for 39% of regional demand, while India represented 21% and Japan contributed 14%. Livestock disease diagnostics accounted for 61% of testing activities because of large poultry and swine farming industries. Veterinary infectious disease outbreaks increased by 18% across the region during 2025, supporting demand for advanced diagnostic technologies and surveillance systems. Veterinary molecular diagnostic installations increased by 41% across Asia-Pacific because of rising government focus on zoonotic disease prevention and food safety monitoring. Portable diagnostic device adoption expanded by 37% among rural veterinary healthcare providers. Companion animal healthcare spending increased by 28%, resulting in 34% growth in canine and feline infectious disease screening procedures. Veterinary laboratories processing over 3,000 samples weekly increased by 26% across major urban centers. Automated immunodiagnostic analyzers improved diagnostic turnaround efficiency by 31% in regional veterinary hospitals.

MIDDLE EAST & AFRICA

The Middle East & Africa accounted for 8% of the Veterinary Infectious Disease Diagnostics Market due to increasing livestock disease control initiatives and improving veterinary healthcare infrastructure. South Africa represented 26% of regional market demand, while Saudi Arabia contributed 19% and the United Arab Emirates accounted for 14%. Livestock disease diagnostics represented 68% of total testing procedures because of strong dependence on cattle, sheep, and poultry farming activities. Veterinary infectious disease screening programs increased by 24% during 2025 across the region. Government-supported zoonotic disease surveillance programs expanded by 31%, supporting veterinary diagnostic laboratory modernization projects. Portable diagnostic devices increased by 27% in rural veterinary healthcare applications because of limited centralized laboratory access. Companion animal healthcare services expanded by 18%, resulting in 21% growth in infectious disease screening procedures among urban veterinary clinics. Molecular diagnostic technologies represented 19% of veterinary laboratory installations during 2025, while immunodiagnostic systems accounted for 48% of diagnostic procedures.

List of Top Veterinary Infectious Disease Diagnostics Companies

• Abbott Laboratories
• Biomérieux SA
• Creative Diagnostics
• HESKA Corporation
• Innovative Diagnostics
• IDEXX Laboratories Inc.
• Neogen Corporation
• Qiagen N.V.
• Randox Laboratories Ltd
• Thermo Fisher Scientific Inc
• Virbac

List of Top 2 Companies Market Share

IDEXX Laboratories Inc. held approximately 24% market share in veterinary infectious disease diagnostics during 2025, supported by over 130,000 veterinary diagnostic instrument installations and more than 2.6 billion annual diagnostic test procedures.

Thermo Fisher Scientific Inc. accounted for nearly 17% market share due to strong molecular diagnostic product portfolios, global veterinary laboratory presence in 50 countries, and 39% growth in veterinary PCR testing system adoption.

Investment Analysis and Opportunities

The Veterinary Infectious Disease Diagnostics Market is attracting substantial investments due to increasing zoonotic disease surveillance programs and rising demand for rapid animal healthcare diagnostics. Global veterinary diagnostic laboratory infrastructure investments increased by 32% during 2025, while molecular diagnostics manufacturing capacity expanded by 28%. Venture capital funding for veterinary biotechnology startups increased by 21%, particularly for artificial intelligence-assisted diagnostic platforms and portable PCR systems. Companion animal healthcare investments represented 57% of total private-sector funding activity in the veterinary diagnostics sector.

Government-supported livestock disease prevention programs expanded by 35%, supporting procurement of advanced veterinary infectious disease testing systems. Asia-Pacific countries increased veterinary healthcare infrastructure spending by 29%, creating strong opportunities for diagnostic equipment manufacturers and laboratory service providers. Portable point-of-care diagnostic technologies represented 33% of investment activity due to increasing demand for decentralized veterinary healthcare. Research collaborations between biotechnology firms and veterinary universities increased by 24%, accelerating innovation in multiplex pathogen detection systems. Veterinary telemedicine platforms integrating cloud-based diagnostic reporting tools expanded by 19%, supporting digital transformation opportunities across veterinary healthcare systems globally.

New Product Development

New product development activities in the Veterinary Infectious Disease Diagnostics Market accelerated during 2025 due to rising demand for faster, portable, and highly accurate disease detection systems. Multiplex PCR diagnostic kits capable of detecting 10 infectious pathogens simultaneously increased by 42% across veterinary laboratories. Artificial intelligence-assisted veterinary imaging platforms improved infectious disease identification accuracy by 33%. Portable handheld diagnostic analyzers generating results within 12 minutes accounted for 31% of newly launched veterinary diagnostic devices during 2025.

Manufacturers expanded development of cloud-connected veterinary diagnostic systems, resulting in 26% improvement in laboratory data sharing efficiency. Biosensor-based infectious disease diagnostic platforms recorded 22% growth in product launches due to rising interest in real-time animal disease monitoring. Companion animal diagnostic products represented 58% of total new product introductions, while livestock disease screening technologies accounted for 42%. Automated nucleic acid extraction systems reduced laboratory processing time by 37%, supporting high-throughput veterinary diagnostic operations. Veterinary diagnostic software integrated with machine learning algorithms improved outbreak prediction accuracy by 18%, strengthening disease surveillance and preventive veterinary healthcare management worldwide.

Five Recent Developments (2023-2025)

• IDEXX Laboratories launched an advanced multiplex canine respiratory disease testing panel during 2024 capable of detecting 12 pathogens simultaneously, improving diagnostic efficiency by 38% across veterinary clinics.
• Thermo Fisher Scientific expanded veterinary PCR manufacturing capacity by 27% in 2025 to support increasing livestock disease surveillance programs and companion animal infectious disease diagnostics demand.
• Qiagen introduced a portable veterinary molecular diagnostic platform during 2023 delivering infectious disease results within 15 minutes and improving field-testing capabilities by 29%.
• Neogen Corporation expanded veterinary pathogen screening operations in 2024 by adding automated testing systems capable of processing 18,000 livestock disease samples daily.
• HESKA Corporation launched cloud-connected veterinary diagnostic analyzers during 2025, improving real-time diagnostic data management efficiency by 24% across veterinary hospitals and laboratories.

Report Coverage of Veterinary Infectious Disease Diagnostics Market

The Veterinary Infectious Disease Diagnostics Market report provides extensive analysis of diagnostic technologies, veterinary healthcare applications, competitive positioning, regional performance, and emerging technological trends. The report evaluates immunodiagnostic, molecular diagnostic, and microbiology-based veterinary testing systems across companion animal and livestock healthcare sectors. More than 45 countries were analyzed for veterinary diagnostic infrastructure development, disease surveillance programs, and laboratory modernization trends during 2025.

The report includes detailed segmentation covering reference laboratories, veterinary clinics, point-of-care testing facilities, and research institutions. Over 120 veterinary diagnostic manufacturers and biotechnology firms were evaluated based on product portfolios, technology innovation, and regional distribution capabilities. Companion animal disease diagnostics represented 57% of total market assessment, while livestock infectious disease screening accounted for 43%. The report also analyzes technological advancements including artificial intelligence-assisted diagnostics, cloud-based laboratory systems, biosensor technologies, and multiplex molecular testing platforms.

Regional analysis covers North America, Europe, Asia-Pacific, and Middle East & Africa with detailed insights regarding market share, diagnostic procedure volumes, veterinary healthcare infrastructure, and disease surveillance initiatives. The report evaluates more than 80 infectious disease categories including bacterial, viral, fungal, and parasitic infections affecting companion animals and livestock. It further examines regulatory compliance trends, veterinary laboratory accreditation standards, investment activities, and technological development strategies shaping the Veterinary Infectious Disease Diagnostics Market during 2025.